EMEA-000694-PIP06-20

Table of contents

Key facts

Invented name
Forxiga
Active substance
dapagliflozin
Therapeutic area
Cardiovascular diseases
Decision number
P/0515/2020
PIP number
EMEA-000694-PIP06-20
Pharmaceutical form(s)
Film-coated tablet
Condition(s) / indication(s)
Treatment of ischaemic heart disease
Route(s) of administration
Oral use
Contact for public enquiries
AstraZeneca AB

E-mail: paediatrics@astrazeneca.com
Tel. +46(8)55324400

Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

Related content

How useful was this page?

Add your rating